• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Dr. Monica Autiero

Dr. Monica Autiero

Dr. Monica Autiero is a Senior Consultant at ToxMinds BVBA and leads ToxMinds’ efforts in the area of non-animal based safety assessments with particular focus on (Q)SAR modelling and identifying analogue and read across-based hazard assessment approaches. She has significant project experience in using in silico tools under various EU regulatory frameworks, particularly with regard to developing read-across justification in line with ECHA’s Read Across Assessment Framework (RAAF) under REACH or the SCCS guidance for the safety evaluation of cosmetic ingredients.

Before joining ToxMinds in 2013, she worked for many years in various positions in academia at the University in Leuven and as project manager in GlaxoSmithKline. Monica is a trained biologist with a Ph.D. in Biochemistry and Molecular Biology from the University Paris XI, France.

Languages: EN, IT, FR

CONTACT

Dr. Monica Autiero
Senior Consultant

Phone: +32 (0)2 762 91 45
Email: contact me

 

SPECIALITIES

Chemicals, Cosmetics, Pharma, Green biotechnology

REACH, QSAR & PPBK modelling, Analogue identification & read-across justification

INSIGHTS & PUBLICATIONS

Mutagenicity assessment of drug impurities according to the ICH M7 (R1) guideline and the role of expert review

Read-across – State of the art and next level!

  • Reducing uncertainty in read across based chemical safety assessments.
    Mishra S, Autiero M, Balteau M, Tencalla F, Petry T. Toxicology Letters 2016, 258:S314.

The Future of Chemical Safety: Moving Beyond Animal Testing

Previous thumb

Dr. Francesca Tencalla

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok